Pilonidal Sinus-Turkey
NCT05519033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1742
Last updated 2022-08-29
Summary
In this research, main purpose is to determine the recurrence prevalence. Destination of the cohort study in which retroprospective data are prospectively reviewed, which aims to identify pilonidal disease subtypes for which various treatment options are indicated, identify various interventions, associate patients with the clinical stage, determine which results are meaningful to patients and which interventions they prefer and provide further research investigation recommendations. .
Primary outcome; To determine the postoperative recurrence rates according to the type of surgical intervention.
The secondary outcome is; to compare the overall patient satisfaction between different operative techniques and to obtain the ratio of different techniques applied for pilonidal sinus treatment in Turkey.
Conditions
- Pilonidal Sinus Treatment
Sponsors & Collaborators
-
Ankara Diskapi Yildirim Beyazit Training and Research Hospital
collaborator UNKNOWN -
Ankara Oncology Research and Training Hospital
collaborator NETWORK -
Gazi University
lead OTHER
Principal Investigators
-
Sezai Leventoglu, Proffesor · Gazi University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2021-06-10
- Completion
- 2021-06-10
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Ohio State University Dermatology Biorepository
NCT03146676 ·Status: RECRUITING
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
NCT01459055 ·Status: UNKNOWN
-
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
NCT04319120 ·Status: RECRUITING
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
NCT05855460 ·Status: UNKNOWN
-
Histopathological Changes in Mycosis Fungoides
NCT05904522 ·Status: RECRUITING ·Phase: NA
-
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
NCT05532865 ·Status: RECRUITING
-
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of Scleredema
NCT04335396 ·Status: UNKNOWN
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
NCT07265999 ·Status: RECRUITING
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Study on the Clinical Features, Comorbidities and Pathologies Associated With Pyoderma Gangrenosum
NCT03636737 ·Status: UNKNOWN
-
Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
NCT02798055 ·Status: COMPLETED
-
International Rare And Severe Psoriasis Expert Network
NCT04359394 ·Status: RECRUITING
-
Characteristics and the Future of the City Chilblains
NCT03101761 ·Status: COMPLETED
-
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
NCT04792957 ·Status: UNKNOWN
-
Establishment of a Patient Library in Patients With Pruritus Sine Materia
NCT05678309 ·Status: NOT_YET_RECRUITING
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Canakinumab for Pyoderma Gangrenosum
NCT01302795 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata
NCT03976622 ·Status: UNKNOWN